Status:
UNKNOWN
PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS
Lead Sponsor:
Alexandria University
Conditions:
Refractory Uremic Pruritis
Eligibility:
All Genders
20-60 years
Phase:
PHASE2
Brief Summary
Patients will be randomly assigned into 2 groups: 1. Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months. 2. Group B: (20 patients) will receive pregabalin oral t...
Eligibility Criteria
Inclusion
- Age: 20-60 years.
- End stage renal disease (the last stage(stage 5) of chronic disease which means kidneys are only functioning at 10 to 15 percent of their normal capacity and dialysis or kidney transplant is necessary to stay alive).
- Refractory uremic pruritis.
Exclusion
- Other causes of pruritis (Dermatological or systemic) e.g. atopic, cholestatic liver disease.
- Photosensitivity.
- Contraindication or allergy to pregabalin.
- Patients on antipruritic drugs e.g. antihistamines, steroids, emollients, opioid agonists.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04660773
Start Date
August 1 2021
End Date
March 1 2022
Last Update
July 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Alexandria, Egypt, 21521